Patients with Idiopathic Intercranial Hypertension (IIH) – a condition which causes raised brain pressure and debilitating headaches – could be treated with an injectable peptide used for type 2 di…

BHP founder-member the University of Birmingham has been awarded a £500k Pathfinder Award from the medical research charity LifeArc which will support early-stage projects with a focus on translati…

Birmingham Health Partners (BHP), the second city’s University-NHS partnership, has announced the inaugural recipients of its Seed Fund programme, awarding more than £300,000 to four projects acros…

Patients experiences of their health conditions are slowly being integrated into AI studies, a review of 25 years of healthcare publications has found. Published in the Lancet Digital Health, th…

Patients with the most common form of leukaemia – Chronic Lymphocytic Leukaemia (CLL) – are being invited to take part in a trial that could help them build Covid-19 antibodies following vaccinatio…

New and innovative ways to detect and treat cancer being trialled at the University of Birmingham are to receive renewed funding from Cancer Research UK and the NIHR. The Birmingham Experimental…